- A
partnership with PAX will allow Organigram to manufacture and fill pods
for the premium, technology-based PAX Era vaporizer
- The
PAX partnership is expected to enable the two entities to seize new
opportunities on the market and work together to develop premium products
featuring disruptive, industry-leading technology that is set to redefine
the experience of vaping
- An
agreement signed with Feather Company Ltd. makes Organigram the exclusive
Canadian supplier of unique and proprietary vaporizer pen technology
- Organigram
is selling to all 10 Canadian provinces
- The
company is on track to increase production capacity and is well positioned
for Canada’s new edibles and derivative legislation, slated for October
2019
Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI), a
leading Canadian licensed producer (LP) of high-quality cannabis and
extract-based products, continues to develop exclusive partnerships and
introduce innovative products that enhance the cannabis lifestyle for its
customers. An exclusive agreement signed with Feather Company Ltd. illustrates
this laser focus on customer experience as Organigram looks forward to Canada’s
legalization of new cannabis product categories, as the company stated in a
news release (http://ibn.fm/T4kfV).
“A successful recreational cannabis market requires that
licensed producers and their partners continually reimagine the cannabis
experience,” Ray Gracewood, senior vice president, marketing and communications
for Organigram, stated in the release. “It is critical for Organigram to find
unique ways to offer customers the kind of value that will help differentiate
our brands. The future is in providing unique opportunities for customers to
explore the product.”
The exclusive agreement between Organigram and Feather, a
cannabis innovator and lifestyle brand committed to the production of
premium-quality products, creates a mutually beneficial relationship for the
two companies. Organigram, through its Edison Cannabis Co. brand,
will hold an exclusive license to Feather’s proprietary vaporizer pen
technology and form factor. Organigram will also represent Feather across
Canada from a commercial perspective and plans to approach all 10 provinces with
Feather’s disposable and cartridge-based units.
“We are thrilled to be working with Organigram,” Feather CEO
Patrick Lehoux stated in the release. “As patients, enthusiasts and advocates
for the cannabis community, we are committed to applying our diverse skills to
produce the best experience for consumers. Our partnership with Organigram
opens new and exciting opportunities for us to do just that. We believe in the
Edison brand and Organigram’s best-in-class facility ensures that we are
partnered with a team committed to producing a consistent, premium product.”
The disposable vaporizer pen and 5/10 thread cartridges for
targeted adult-use customer segments are expected to be available as this
product category becomes legal in Canada by mid-October 2019. Feather’s
technology and hardware offers Organigram’s Edison brand a unique, proprietary
delivery mechanism for discerning and sophisticated consumers and will
complement the company’s partnership with PAX, a leader in closed-loop
vaporizable technology offered through the PAX Era product line (http://ibn.fm/lXIpJ).
Organigram is planning on working with and offering the
Edison Cannabis Co.-branded PAX Era pods to all 10 of its provincial partners
to achieve coast-to-coast distribution. The pods will be filled onsite at
Organigram’s Moncton facility at the company’s phase 5 refurbishment.
As concentrates are anticipated to become legal in Canada
later in 2019, giving birth to a wide range of new market development
opportunities, strategic partnerships like the one between Organigram and PAX
Labs are expected to allow the immediate launch of premium products featuring a
disruptive, industry-leading technology that is set to redefine the experience
of vaping.
“Cannabis 2.0 – the next generation of legal, adult use
cannabis products – represents a world of opportunity,” Organigram CEO Greg
Engel added. “Innovative partnerships with exceptional companies like PAX mean
our own product offering grows and our customers have access to cutting-edge
technology and cannabis experiences.”
The agreement with PAX reflects Organigram’s strategic
commitment to growth and leadership through technology-driven innovation.
Additionally, the company has been building up significant levels of
concentrate in anticipation of the Canadian legislative change and the launch
of Cannabis 2.0 vape pens and edibles later in 2019. According to Engel, this
is just the beginning for his company, whose team is strongly committed to
developing exceptional and imaginative products that support both the
organization’s business objectives and its customers’ needs.
Further cementing its position, Organigram earlier in 2019
secured distribution agreements in all 10 Canadian provinces, becoming one of just
three licensed producers in Canada to do so (http://ibn.fm/NCowK). The company boasts the lowest cost of
cultivation among Canadian licensed producers, driven by industry-leading
yields.
For more information, visit the company’s website at www.Organigram.ca
NOTE TO INVESTORS: The latest news and updates
relating to OGI are available in the company’s newsroom at http://ibn.fm/OGRMF
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given
situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
